Detailed information for compound 943366

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 504.667 | Formula: C29H40N6O2
  • H donors: 3 H acceptors: 3 LogP: 5.91 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 2
  • SMILES: O=C(Nc1ccc2c(n1)cccc2)N[C@@H]1CCC[C@@H](C1)C[C@@]1(CCC2CCCCC2)NC(=N)N(C1=O)C
  • InChi: 1S/C29H40N6O2/c1-35-26(36)29(34-27(35)30,17-16-20-8-3-2-4-9-20)19-21-10-7-12-23(18-21)31-28(37)33-25-15-14-22-11-5-6-13-24(22)32-25/h5-6,11,13-15,20-21,23H,2-4,7-10,12,16-19H2,1H3,(H2,30,34)(H2,31,32,33,37)/t21-,23+,29+/m0/s1
  • InChiKey: HAYVUYMTLMAYFA-WMEWVQGBSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens beta-site APP-cleaving enzyme 1 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma mansoni memapsin-2 (A01 family) Get druggable targets OG5_135830 All targets in OG5_135830
Schistosoma japonicum ko:K07747 beta-site APP-cleaving enzyme 2 (memapsin 1) [EC3.4.23.45], putative Get druggable targets OG5_135830 All targets in OG5_135830

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Plasmodium falciparum plasmepsin VII beta-site APP-cleaving enzyme 1 401 aa 352 aa 21.3 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0403 0.4962 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0403 0.4962 0.5
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0403 0.4962 1
Loa Loa (eye worm) oxidoreductase 0.0403 0.4962 0.5
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0403 0.4962 1
Onchocerca volvulus 0.0403 0.4962 0.5
Toxoplasma gondii aldose reductase, putative 0.0403 0.4962 0.5
Trichomonas vaginalis aldo-keto reductase, putative 0.0403 0.4962 0.5
Onchocerca volvulus 0.0403 0.4962 0.5
Trichomonas vaginalis aldo-keto reductase, putative 0.0403 0.4962 0.5
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0403 0.4962 1
Trypanosoma cruzi aldo-keto reductase 0.0403 0.4962 0.5
Leishmania major aldo-keto reductase-like protein 0.0403 0.4962 0.5
Trichomonas vaginalis aldo-keto reductase, putative 0.0403 0.4962 0.5
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0403 0.4962 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0403 0.4962 0.5
Leishmania major aldehyde reductase, putative,oxidoreductase, putative 0.0403 0.4962 0.5
Trypanosoma brucei aldo-keto reductase, putative 0.0403 0.4962 0.5
Echinococcus multilocularis aldo keto reductase 0.0403 0.4962 1
Onchocerca volvulus 0.0403 0.4962 0.5
Loa Loa (eye worm) oxidoreductase 0.0403 0.4962 0.5
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0403 0.4962 1
Loa Loa (eye worm) hypothetical protein 0.0403 0.4962 0.5
Echinococcus multilocularis aldo keto reductase 0.0403 0.4962 1
Onchocerca volvulus 0.0403 0.4962 0.5
Mycobacterium leprae PROBABLE OXIDOREDUCTASE 0.0403 0.4962 1
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.0403 0.4962 0.5
Echinococcus granulosus aldo keto reductase 0.0403 0.4962 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0403 0.4962 1
Loa Loa (eye worm) oxidoreductase 0.0403 0.4962 0.5
Echinococcus granulosus aldo keto reductase 0.0403 0.4962 1
Echinococcus granulosus aldo keto reductase 0.0403 0.4962 1
Onchocerca volvulus 0.0403 0.4962 0.5
Entamoeba histolytica aldose reductase, putative 0.0403 0.4962 0.5
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.0403 0.4962 0.5
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0403 0.4962 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0403 0.4962 0.5
Trichomonas vaginalis aldo-keto reductase, putative 0.0403 0.4962 0.5
Echinococcus multilocularis aldo keto reductase 0.0403 0.4962 1
Trypanosoma cruzi aldo/keto reductase, putative 0.0403 0.4962 0.5
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0403 0.4962 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0403 0.4962 0.5
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0403 0.4962 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0403 0.4962 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0403 0.4962 1
Giardia lamblia Aldose reductase 0.0403 0.4962 0.5
Trichomonas vaginalis aldo-keto reductase, putative 0.0403 0.4962 0.5
Leishmania major prostaglandin f synthase, putative 0.0403 0.4962 0.5
Echinococcus granulosus hypothetical protein 0.0403 0.4962 1
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0403 0.4962 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0403 0.4962 1
Trichomonas vaginalis dihydrodiol dehydrogenase, putative 0.0403 0.4962 0.5
Trichomonas vaginalis dihydrodiol dehydrogenase, putative 0.0403 0.4962 0.5
Trichomonas vaginalis aldo/keto reductase, putative 0.0403 0.4962 0.5
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0403 0.4962 1
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0403 0.4962 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0403 0.4962 0.5
Loa Loa (eye worm) oxidoreductase 0.0403 0.4962 0.5
Leishmania major prostaglandin f2-alpha synthase/D-arabinose dehydrogenase 0.0403 0.4962 0.5
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.0403 0.4962 0.5
Trichomonas vaginalis aldo/keto reductase, putative 0.0403 0.4962 0.5
Trichomonas vaginalis aldo-keto reductase, putative 0.0403 0.4962 0.5
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0403 0.4962 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0403 0.4962 1
Mycobacterium ulcerans oxidoreductase 0.0403 0.4962 0.5
Trichomonas vaginalis dihydrodiol dehydrogenase, putative 0.0403 0.4962 0.5
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0403 0.4962 1
Giardia lamblia Aldose reductase 0.0403 0.4962 0.5
Mycobacterium tuberculosis Probable oxidoreductase 0.0403 0.4962 0.5
Trichomonas vaginalis aldo-keto reductase, putative 0.0403 0.4962 0.5
Entamoeba histolytica aldose reductase, putative 0.0403 0.4962 0.5
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.0403 0.4962 0.5
Entamoeba histolytica aldose reductase, putative 0.0403 0.4962 0.5
Echinococcus multilocularis aldo keto reductase 0.0403 0.4962 1
Onchocerca volvulus 0.0403 0.4962 0.5
Trichomonas vaginalis aldo/keto reductase, putative 0.0403 0.4962 0.5
Loa Loa (eye worm) oxidoreductase 0.0403 0.4962 0.5
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0403 0.4962 1
Trypanosoma brucei prostaglandin f synthase 0.0403 0.4962 0.5

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) Reduction of cortical amyloid beta 40 level in CRND8-APP mouse model ChEMBL. 25455483
EC50 (binding) = 110 nM Inhibition of BACE1-mediated amyloid beta 40 production in HEK293-APPswe/lon cells by whole cell assay in presence of P-gp inhibitor ChEMBL. 25455483
EC50 (binding) = 258 nM Inhibition of BACE1-mediated amyloid beta 40 production in HEK293-APPswe/lon cells by whole cell assay ChEMBL. 25455483
Ki (binding) = 22 nM Inhibition of purified human BACE1 by FRET assay ChEMBL. 25455483
Ki (binding) = 25 uM Inhibition of cathepsin-D (unknown origin) ChEMBL. 25455483

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.